These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2498272)

  • 1. Structure activity relationships in PIPC-analogues against Pseudomonas aeruginosa.
    Mitsuyama J; Hori R; Ito Y; Yotsuji A; Yasuda T; Saikawa I
    J Antibiot (Tokyo); 1989 Apr; 42(4):598-603. PubMed ID: 2498272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of piperacillin-analogues in vitro; effect of the carbon number at the N-4 position of 2,3-dioxopiperazine on the outer membrane permeability, stability to beta-lactamase and binding affinity to penicillin-binding proteins.
    Mitsuyama J; Takahata M; Yasuda T; Saikawa I
    J Antibiot (Tokyo); 1987 Jun; 40(6):868-72. PubMed ID: 3301774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis.
    Parr TR; Chan L; Bayer AS
    Chemotherapy; 1988; 34(6):478-83. PubMed ID: 3149570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
    Mett H; Schacher B; Schneider P; Zak O
    Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5.
    Livermore DM
    J Antimicrob Chemother; 1987 Jun; 19(6):733-42. PubMed ID: 3112099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbapenem antibiotics].
    Watanabe A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():737-43. PubMed ID: 12722309
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Peters J; Parr TR; Chan L; Hancock RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):253-8. PubMed ID: 3105450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbenicillin resistance of Pseudomonas aeruginosa.
    Rodríguez-Tebar A; Rojo F; Dámaso D; Vázquez D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):255-61. PubMed ID: 6821456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa.
    Livermore DM
    J Med Microbiol; 1984 Oct; 18(2):261-70. PubMed ID: 6092639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.
    Vurma-Rapp U; Kayser FH; Hadorn K; Wiederkehr F
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):580-7. PubMed ID: 2120059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
    Watanabe N; Sugiyama I
    J Antibiot (Tokyo); 1992 Sep; 45(9):1526-32. PubMed ID: 1429239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ; Drusano GL; Mobley HL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1892-6. PubMed ID: 3125787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp.
    Theron MM; van Rensburg MN; Chalkley LJ
    J Antimicrob Chemother; 2003 Jul; 52(1):120-2. PubMed ID: 12805259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.
    Quinn JP; Dudek EJ; DiVincenzo CA; Lucks DA; Lerner SA
    J Infect Dis; 1986 Aug; 154(2):289-94. PubMed ID: 3088133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.